BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28956132)

  • 1. VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment.
    Nowicki M; Wierzbowska A; Małachowski R; Robak T; Grzybowska-Izydorczyk O; Pluta A; Szmigielska-Kapłon A
    Ann Hematol; 2017 Dec; 96(12):2103-2112. PubMed ID: 28956132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of hematopoietic niche cytokines and their influence on mobilization efficacy and timing in patients with hematological malignancies.
    Szmigielska-Kaplon A; Krawczynska A; Czemerska M; Pluta A; Cebula-Obrzut B; Robak M; Grzybowska-Izydorczyk O; Szmigielska K; Robak T; Wierzbowska A
    J Clin Apher; 2015 Aug; 30(4):247-51. PubMed ID: 25352518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-15a, miRNA-16, miRNA-126, miRNA-146a, and miRNA-223 expressions in autologous hematopoietic stem cell transplantation and their impact on engraftment.
    Nowicki M; Szemraj J; Wierzbowska A; Misiewicz M; Małachowski R; Pluta A; Grzybowska-Izydorczyk O; Robak T; Szmigielska-Kapłon A
    Eur J Haematol; 2018 May; 100(5):426-435. PubMed ID: 29380440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent regulation of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor by hypoxia and female sex steroids in human endometrial stromal cells.
    Tsuzuki T; Okada H; Cho H; Shimoi K; Miyashiro H; Yasuda K; Kanzaki H
    Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):95-101. PubMed ID: 23352606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
    Świerzko AS; Michalski M; Sokołowska A; Nowicki M; Eppa Ł; Szala-Poździej A; Mitrus I; Szmigielska-Kapłon A; Sobczyk-Kruszelnicka M; Michalak K; Gołos A; Wierzbowska A; Giebel S; Jamroziak K; Kowalski ML; Brzezińska O; Thiel S; Jensenius JC; Kasperkiewicz K; Cedzyński M
    Front Immunol; 2018; 9():2153. PubMed ID: 30294330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietins in haematopoietic stem cell mobilisation in patients with haematological malignancies.
    Szmigielska-Kaplon A; Krawczynska A; Czemerska M; Pluta A; Cebula-Obrzut B; Szmigielska K; Stępka K; Smolewski P; Robak T; Wierzbowska A
    Blood Transfus; 2015 Jan; 13(1):102-8. PubMed ID: 25369606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation.
    Gonçalves TL; Benvegnú DM; Bonfanti G
    Oxid Med Cell Longev; 2009; 2(2):82-7. PubMed ID: 20357929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Level of vascular endothelial growth factor predicts both relapse and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
    Moiseev IS; Lapin SV; Surkova EA; Lerner MY; Vavilov VN; Afanasyev BV
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1677-82. PubMed ID: 24035780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin 1 and angiopoietin 2 in follicular fluid of women undergoing a long protocol.
    Nishigaki A; Okada H; Tsuzuki T; Cho H; Yasuda K; Kanzaki H
    Fertil Steril; 2011 Dec; 96(6):1378-83. PubMed ID: 22000910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma.
    Akkök CA; Hervig T; Stamnesfet S; Nesthus I; Melve GK; Lassalle P; Bruserud O
    Cytotherapy; 2011 Nov; 13(10):1259-68. PubMed ID: 21905955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Willebrand Factor and Platelet Levels before Conditioning Chemotherapy Indicate Bone Marrow Regeneration following Autologous Hematopoietic Stem Cell Transplantation.
    Radnay Z; Illés Á; Udvardy M; Prohászka Z; Sinkovits G; Csányi MC; Kellermayer M; Kiss A; Hársfalvi J
    Transplant Cell Ther; 2022 Dec; 28(12):830.e1-830.e7. PubMed ID: 36058547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone-marrow-derived endothelial precursor cells into brain tumors.
    Udani V; Santarelli J; Yung Y; Cheshier S; Andrews A; Kasad Z; Tse V
    Neurol Res; 2005 Dec; 27(8):801-6. PubMed ID: 16354539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-2, Angiopoietin-1 and subclinical cardiovascular disease in Chronic Kidney Disease.
    Tsai YC; Lee CS; Chiu YW; Kuo HT; Lee SC; Hwang SJ; Kuo MC; Chen HC
    Sci Rep; 2016 Dec; 6():39400. PubMed ID: 27991547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
    de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
    Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy/autologous hematopoietic stem cell transplantation.
    Boutsikas G; Terpos E; Papatheodorou A; Tsirkinidis P; Tsirigotis P; Meletiou A; Lalou E; Telonis V; Zannou A; Kanellopoulos A; Galani Z; Stefanou A; Tsaftaridis P; Viniou NA; Panayiotidis P; Kyrtsonis MC; Meletis J; Vassilakopoulos TP; Angelopoulou MK
    Eur J Haematol; 2018 Feb; 100(2):131-139. PubMed ID: 29105864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological markers of hemostasis and endothelial activation in patients with a hematological malignancy with or without stem cell transplants.
    Buser TA; Martinez M; Drexler B; Tschan-Plessl A; Heim D; Passweg J; Tsakiris DA
    Eur J Haematol; 2019 Nov; 103(5):472-477. PubMed ID: 31390488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
    Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH
    Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of angiopoietin 1 and 2 in ectopic endometrium on the chicken chorioallantoic membrane.
    Drenkhahn M; Gescher DM; Wolber EM; Meyhoefer-Malik A; Malik E
    Fertil Steril; 2004 Mar; 81 Suppl 1():869-75. PubMed ID: 15019822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinetics and apoptotic profile of circulating endothelial cells in autologous hematopoietic stem cell transplantation in patients with lymphoproliferative disorders.
    Szmigielska-Kaplon A; Krawczynska A; Czemerska M; Pluta A; Cebula-Obrzut B; Grzybowska-Izydorczyk O; Wolska A; Szmigielska K; Smolewski P; Robak T; Wierzbowska A
    Ann Hematol; 2013 Sep; 92(9):1255-62. PubMed ID: 23636312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
    Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
    Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.